PH vs RNAC · P/E 28, rev $19.85B vs P/E 2.1, rev $38.9M
Parker-Hannifin Corporation (PH) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
PH currently screens at market cap $91.89B and trailing P/E 27.7. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the PH and RNAC stock pages for the full models.
Not investment advice.